Treatment of sporadic encephalitis with thymosin and nerve growth factor extracted from human embryo

Li GuangxianZheng ZhiQi YanchaoBuxiaWang YanfangZhang Xiangling

1. Department of Neurology, 152 Hospital of PLA2. Department of Neurology, 152 Hospital of PLA3. Henan Cancer Research Institute 4. Henan Cancer Research Institute5. Henan Cancer Research Institute6. Department of Neurology, General Hospital of Pingdingshan Mining Bureau, Henan Province

Abstract: thymosin treatment of immune diseases has been affirmed, but at the end of the treatment of sporadic encephalitis (scattered brain) report. Nerve Growth Factor (NGF) is a new discovery that won the 1986 Nobel Prize in Medicine and Physiology. It is of great significance to the development, growth and maintenance of nerve cells, but it is currently limited to extraction from animals and animal experiments. The extraction of thymosin and NGF from human embryos is used in clinical applications. There is no research report on this at home and abroad. We have tried to treat 20 cases of scattered brain and achieved satisfactory results. The report is as follows.

• DOI:10.19845/j.cn ki. zfysjbzz.1993.02.032
• Album: Medical and Health Technology
• Special Topics: Neurology
• Human embryo extraction thymosin and nerve growth factor for the treatment of sporadic encephalitis_Li Guangxian.pdf